The U.S. Food and Drug Administration first approved mifepristone in 2000, and the drug has since become the most common method of abortion in the United States, accounting for 65% of all U.S. abortions in 2023

US health policy & drug pricing

Evolving US policy battles over drug pricing and healthcare affordability, tracking legislation, court rulings, regulatory actions, and industry responses shaping costs, access, and market dynamics.

218 claims·78 news stories